Results 71 to 80 of about 34,611,146 (146)
Pulmonary fibrosis (PF), a progressive and fatal disease, is characterized by fibroblast proliferation, excessive extracellular matrix deposition, and collagen synthesis. These pathological changes lead to impaired lung structure and function, ultimately
Changhui Lang +7 more
doaj +1 more source
Background Angiotensin‐converting enzyme 2 (ACE2) is a homologue of angiotensin‐converting enzyme (ACE) and produces angiotensin peptides (APs), such as angiotensin 1‐9 and 1‐7 that are vasodilatory and natriuretic, and act to counterbalance angiotensin ...
Éva Larouche‐Lebel +8 more
doaj +1 more source
Impact of angiotensin converting enzyme inhibition on post- coronary artery bypass interleukin 6 release [PDF]
Background: Angiotensin 1 converting enzyme (ACE) inhibitors reduce morbidity and mortality after coronary artery bypass graft surgery (CABG). This benefit may result from an anti- inflammatory action.
Humphries, S.E. +5 more
core +2 more sources
Myocardial and Renal Renin–Angiotensin System Enzyme Activity in Dogs
Background Methods to quantify the activity of the tissue renin–angiotensin system (RAS) are needed. Objective To estimate myocardial and renal RAS enzyme activity in postmortem tissues.
Emma C. Weitzhandler +3 more
doaj +1 more source
Artículo de publicación ISIInsulin-like growth factor-1, angiotensin-(1-7) and angiotensin-(1-9) have been proposed to be important mediators in cardioprotection. A large body of evidence indicates that insulin like growth factor-1 has pleotropic actions
Paz Ocaranza, María +9 more
core +1 more source
Angiotensin-(1-7): Pharmacological properties and pharmacotherapeutic perspectives
Therapeutic modulation of the renin-angiotensin system is not complete without taking into consideration the beneficial effects of angiotensin-(1-7) in cardiovascular pathology.
Dilek Iusuf +12 more
core +1 more source
Objective Angiotensin-converting enzyme (ACE) inhibitors provide effective intervention for cardiovascular and renal disease. Changes in angiotensin-(1-7) have been proposed to be involved in the mechanism of action of ACE inhibition (ACEi).
Kocks, MJA +6 more
core +1 more source
Angiotensin-converting enzyme (ACE) catalyzes the formation of angiotensin II (Ang II), a vasoconstrictor, whereas its homologue ACE2 degrades Ang II into angiotensin (1–7) (Ang (1–7)), a vasodilator.
Zihan Wang (3129810) +3 more
core +1 more source
Metabolic Inactivation of Angiotensin 1-7 (Ang 1-7)
The renin-angiotensin system (RAS) plays a role in the control of the cardiovascular system by modulating blood pressure. While Angiotensin II (Ang II) serves as a vasoconstrictor and is the most well-known of the RAS peptides, Angiotensin 1-7 (Ang 1-7 ...
Abraham, Christy, Asif, Mahnoor
core +1 more source
Shan Zhang, Min Sheng, Dan Yu, Kechen Qian, Yichen Zhang, Wenhan Huang, Feifeng Ren, Lin Tang Department of Rheumatology and Immunology, Second Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaCorrespondence: Lin ...
Ren F +7 more
core

